Tumor-supportive oncometabolism studies stated that Cav-1 enables re-modification of cancer cell lipid metabolism toward increased sphingomyelins catabolism to ceramide derivatives and changes ceramide metabolism in cancer cells. This evidence concerns the gene CAV1 and cancer.